Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1002/AJMG.A.63313 | ||||
| Año | 2023 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
PUF60-related developmental disorder (also referred to as Verheij syndrome), resulting from haploinsufficiency of PUF60, is associated with multiple congenital anomalies affecting a wide range of body systems. These anomalies include ophthalmic coloboma, and congenital anomalies of the heart, kidney, and musculoskeletal system. Behavioral and intellectual difficulties are also observed. While less common than other features associated with PUF60-related developmental disorder, for instance hearing impairment and short stature, identification of specific anomalies such as ophthalmic coloboma can aid with diagnostic identification given the limited spectrum of genes linked with this feature. We describe 10 patients with PUF60 gene variants, bringing the total number reported in the literature, to varying levels of details, to 56 patients. Patients were recruited both via locally based exome sequencing from international sites and from the DDD study in the United Kingdom. Eight of the variants reported were novel PUF60 variants. The addition of a further patient with a reported c449-457del variant to the existing literature highlights this as a recurrent variant. One variant was inherited from an affected parent. This is the first example in the literature of an inherited variant resulting in PUF60-related developmental disorder. Two patients (20%) were reported to have a renal anomaly consistent with 22% of cases in previously reported literature. Two patients received specialist endocrine treatment. More commonly observed were clinical features such as: cardiac anomalies (40%), ocular abnormalities (70%), intellectual disability (60%), and skeletal abnormalities (80%). Facial features did not demonstrate a recognizable gestalt. Of note, but remaining of unclear causality, we describe a single pediatric patient with pineoblastoma. We recommend that stature and pubertal progress should be monitored in PUF60-related developmental disorder with a low threshold for endocrine investigations as hormone therapy may be indicated. Our study reports an inherited case with PUF60-related developmental disorder which has important genetic counseling implications for families.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Grimes, H. | - |
Univ Hosp Bristol & Weston NHS Trust - Reino Unido
University Hospitals Bristol and Weston NHS Foundation Trust - Reino Unido |
| 2 | Ansari, M. | - |
Western Gen Hosp - Reino Unido
Western General Hospital - Reino Unido |
| 3 | Ashraf, T. | - |
Great Ormond St Hosp Sick Children - Reino Unido
Great Ormond Street Hospital for Children NHS Foundation Trust - Reino Unido |
| 4 | Cueto-Gonzalez, Anna M. | Mujer |
Vall Hebron Barcelona Hosp Campus - España
Autonomous Univ Barcelona - España Universitat Autònoma de Barcelona - España |
| 5 | Calder, A. | - |
Great Ormond St Hosp Sick Children - Reino Unido
Great Ormond Street Hospital for Children NHS Foundation Trust - Reino Unido |
| 6 | Day, M. | - |
Royal Devon & Exeter NHS Trust - Reino Unido
Royal Devon and Exeter NHS Foundation Trust - Reino Unido |
| 7 | Fernandez Alvarez, P. | - |
Vall Hebron Barcelona Hosp Campus - España
|
| 8 | Foster, A. | - |
West Midlands Reg Genet Ctr - Reino Unido
West Midlands Regional Genetics Laboratory - Reino Unido |
| 9 | Lahiri, N. | - |
St Georges Univ Hosp NHS Fdn Trust - Reino Unido
St Georges Univ London - Reino Unido St George's University Hospitals NHS Foundation Trust - Reino Unido St George’s, University of London - Reino Unido |
| 10 | REPETTO-LISBOA, MARIA GABRIELA | Mujer |
Universidad del Desarrollo - Chile
Facultad de Medicina Clínica Alemana Universidad del Desarrollo - Chile |
| 11 | Scurr, I. | Mujer |
Univ Hosp Bristol & Weston NHS Trust - Reino Unido
University Hospitals Bristol and Weston NHS Foundation Trust - Reino Unido |
| 12 | Varghese, V. | Hombre |
Univ Hosp Wales - Reino Unido
University Hospital of Wales - Reino Unido |
| 13 | Low, Karen | Mujer |
Univ Hosp Bristol & Weston NHS Trust - Reino Unido
Univ Bristol - Reino Unido University Hospitals Bristol and Weston NHS Foundation Trust - Reino Unido Centre for Academic Child Health - Reino Unido |
| Fuente |
|---|
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| Wellcome Trust |
| Health Innovation Challenge Fund |
| Wellcome |
| Department of Health |
| Wellcome Sanger Institute |
| Agencia Nacional de Investigación y Desarrollo |
| Department of Health and Social Care |
| ANID Chile FONDECYT |
| Cambridge South REC |
| National Institute for Health and Care Research |
| Republic of Ireland REC |
| European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA |
| Australian Centre for Geomechanics |
| Agradecimiento |
|---|
| Health Innovation Challenge Fund, Grant/Award Number: HICF-1009-003; Wellcome and the Department of Health; Wellcome Sanger Institute, Grant/Award Number: WT098051; Cambridge South REC, Grant/Award Number: 10/H0305/83; Republic of Ireland REC, Grant/Award Number: GEN/284/12; ANID Chile FONDECYT, Grant/Award Number: 1211411; European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA, Grant/Award Number: 3HP-HP-FPA ERN-01-2016/739516 |
| The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (Grant number HICF-1009-003), a parallel funding partnership between Wellcome and the Department of Health, and the Wellcome Sanger Institute (Grant number WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of Wellcome or the Department of Health. The study has UK Research Ethics Committee approval (10/H0305/83, granted by the Cambridge South REC, and GEN/284/12 granted by the Republic of Ireland REC). The research team acknowledges the support of the National Institute for Health Research through the Comprehensive Clinical Research Network. GMR is funded by ANID Chile FONDECYT (Grant number 1211411). One of the author(s) (ACG) of this publication is a member of the European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA (EU Framework Partnership Agreement ID: 3HP-HP-FPA ERN-01-2016/739516). |